ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LYEL Lyell Immunopharma Inc

2.36
-0.04 (-1.67%)
May 03 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 3.62M1.68M36.91M1.25M49.6M1.35M596k317k
Operating Income -47.54M-68.58M-37.26M-66.44M-14.78M-62.56M-65.91M-59.04M
Pre Tax Income -83.71M-68.14M-36.32M-70.25M-8.4M-66.96M-63.89M-50.85M
Net Income -83.71M-68.14M-36.32M-70.25M-8.4M-66.96M-63.89M-50.85M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -47.58M-68.54M-37.28M-67.48M-12.9M-61.46M-66.23M-57.46M
EBITDA -43.1M-64.39M-33.09M-61.82M-9.74M-57.53M-60.84M-53.94M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 657k17.19M12.97M89.44M2.92M
Operating Income -102.09M-211.94M-214.78M-187.06M-247.01M
Pre Tax Income -129.38M-204.47M-250.22M-183.12M-234.63M
Net Income -129.38M-204.47M-250.22M-183.12M-234.63M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -11.571-13.132-1.031-0.734-0.932
EBIT -137.5M-210.41M-214.94M-185.17M-245.16M
EBITDA -100.83M-207.64M-201.28M-169.04M-226.76M

Your Recent History

Delayed Upgrade Clock